PD models with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine reported decreased TH expression in the SNc with no evident neuron loss after 7 days of post-single low dose exposure (Alam et al., 2017). Here, TH is linked to Parkinson disease.